Citations

Clear

7 citation(s) found for "Johnson, Rachel".

B22-01 Local Ancestral Loci Associated With Lung Function in African American Asthma Populations
Shrivastav, A, Slack, S, Zein, J G, Chiarella, S E, Althoff, M D, Daya, M, Cardet, J C, Hastie, A T, Hawkins, G A, Moore, W C, Barnes, K, Busse, W W, Castro, M, Denlinger, L C, Erzurum, S C, Jackson, D J, Jarjour, N N, Levy, I, Mauger, D, Szefler, S J, Israel, E, Wenzel, S E, Wechsler, M E, Bleecker, E R, Meyers, D A, Johnson, R K, Ortega, V E, Zein, Joe , Althoff, Meghan D. , Daya, Michelle , Cardet, Juan Carlos , Hastie, Annette T. , Denlinger, Loren C. , Szefler, SJ, Israel, Elliot , Wenzel, Sally E. , Wechsler, Michael E , Meyers, Deborah A. , Johnson, Rachel K.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.393 Get It

Abstract Rationale Higher African genetic ancestry has been associated with lower lung function, among individuals from specific racial-ethnic groups. The influence and interactions of genetic variation and ancestry in lung function is poorly understood. This study investigates ancestry-associated loci influencing lung function via admixture mapping and fine-scale allelic association. Methods 512 African American patients with asthma (≥12 years) from the Severe Asthma Research Program and Collaborative Study on the Genetics of Asthma (SARP/CSGA) cohorts were genotyped on the OmniExpress and HumanHap1M arrays or had whole-genome sequencing (WGS). For admixture mapping, global ancestry was inferred using ADMIXTURE and local ancestry estimated using RFMix v1.5.4 with CEU (N = 99) and YRI (N = 108) references across 15,095 local ancestry segments. Peak regions and contiguous segments (p < 10-3) were fine mapped in SARP using local ancestry estimated from WGS with MAF ≥0.03. The Local Ancestry Adjusted Allelic Association (LAAA) model was used to fine map local genetic effect, local ancestry effect, and the interaction between the two, adjusted for age, sex, height, BMI, cohort, and percentage global African ancestry. SNPs with local genetic or interaction p < 10⁻³ were tested for replication in 282 adolescent/adult participants from the Best African Response to Asthma Drugs (BARD) cohort genotyped with the MEGA array imputed to TOPMed (MAF ≥0.03). Results Mean African genetic ancestry was 81.3% in SARP and 80.1% in BARD. In SARP, African genetic ancestry was inversely associated with lung function (FEV₁:β = −7.9, p = 0.005; FVC:β = −9.0, p = 0.004), with stronger effects in females (FEV₁: β = −9.3, p = 0.003; FVC: β = −11.4, p = 0.001) than males (FEV₁:β = −6.4, p = 0.237; FVC:β = −5.7, p = 0.340). Similar total and sex-specific associations were identified in BARD. Admixture mapping in SARP/CSGA identified significant peaks for maximum FVC (p < 1.87 × 10⁻4) on chromosomes 8 and 17 near RP1 and RBFOX3, and near-significant peaks on chromosome 5 near IQGAP2, SNRPCP2, SV2C and for the maximum FEV₁/FVC ratio on chromosome 10 near PCDH15. Fine mapping identified the top SNP on chromosome 8 (rs73587686; p-allele-dose=9.0x10-5; RGS20; q11.23), with 62 additional SNPs overlapping RGS20. SNP rs7825816 was also identified in SARP (β = 2.35, p-allele-dose =1.03 × 10⁻4) and replicated in BARD (β = 1.15, p-allele-dose =0.03). In BARD, LAAA also identified eight additional SNPs (p ≤ 0.05) in the same LD block (chr8:53914976-53918297) overlapping with RGS20, ATP6V1H, and TCEA1. Conclusions We identified multiple chromosomal regions associated with lung function in asthma patients of predominantly African genetic ancestry. Lung function associations were strongest at genetic variation near a key that was replicated in an independent asthma cohort. This abstract is funded by: R01 K08 HL118128, R01 HL142992, R01 NR013700, R01 HL69167, R01 HL161674, HL69116, HL69167, HL69170, HL69174, U10 HL109164, U10 HL109257, U10 HL109146, U10 HL109172, U10 HL109250, U10 HL109250, U10 HL109250, U10 HL109168, U10 HL109152, U10 HL109086-04, U10 HL098115, HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103, and K12 HL89992
Toward a Diagnostic Template for Acquired Apraxia of Speech: Insights From an Academy of Neurologic Communication Disorders Review
King, Charlotte , Bislick, Lauren , Nealon, Kate , Johnson, Rachel, Utianski, Rene L. , Wambaugh, Julie , Haley, Katarina L. , Wambaugh, Julie L. , Johnson, Rachel K. , Johnson, Rachel , Utianski, Rene L , Haley, Katarina L

Mayo Clinic

American Journal of Speech-Language Pathology | April 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.1044/2026_ajslp-25-00433 | PMID 42017773 Get It

Purpose: Significant variation is observed in diagnostic assessments for individuals with acquired apraxia of speech (AOS). The lack of consistency across research related to AOS impacts the comparison of intervention outcomes. This extends to diagnostic criteria, assessment, and the inclusion of patient demographics. This viewpoint examines outcomes related to the consistency in diagnostic tool use and collection of demographic information and introduces a template to support researchers and clinicians conducting diagnostic evaluations. Materials include guidelines for a thorough case history, current diagnostic characteristics, and diagnostic assessment tools available for describing AOS. The template illustrates how such materials can be structured and applied in research and clinical practice. Method: The recommendations provided in this viewpoint are part of a recent systematic review about AOS treatment outcomes. Trained raters extracted data from a comprehensive literature search from 1951 to April 2024 using a consensus protocol. Results: Of the 92 studies included in data extraction, demographic information such as age, gender, etiology, and months post-onset was commonly reported, and information about race and ethnicity (described in 15% of studies), socioeconomic status (0%), current/previous occupation (8%), language history (10%), and education (59%) was described less frequently. Reported diagnostic characteristics varied across studies, reflecting differences in using discriminatory versus nondiscriminatory features. Concomitant diagnoses, such as aphasia severity (37%) and presence of dysarthria (32%), were not consistently reported or described. Conclusion: A template with specific criteria and assessments can support research replication, raise awareness of diagnostic strategies, and offer a structured framework for investigators and clinicians. Supplemental Material: https://doi.org/10.23641/asha.32012346
Underreported Demographic Factors in Apraxia of Speech Treatment Studies: Recommendations for Inclusive Research
Bislick, Lauren , Utianski, Rene L., King, Charlotte , Nealon, Kate , Johnson, Rachel K. , Haley, Katarina L. , Utianski, Rene L. , Utianski, Rene L , Johnson, Rachel , Haley, Katarina L , Wambaugh, Julie L.

Mayo Clinic

Journal of Speech, Language, and Hearing Research | February 5, 2026 | Volume: 69 | Issue: 3 | Pages: 998-1006

10.1044/2025_jslhr-25-00532 | PMID 41642095 Get It

Purpose: While acquired apraxia of speech (AOS) has been the focus of intervention research for decades, little information is reported about the demographic representation of study participants. This article examines the extent to which published AOS treatment studies report participants' age, sex/gender, race/ethnicity, language background, and socioeconomic status; identifies critical gaps in the literature; and considers implications for representativeness. This information supports the important call to capture these patient factors systematically and thereby advance equity in research and clinical care. Method: This study is part of a larger systematic review examining treatment outcomes for acquired AOS. A comprehensive search of databases from 1951 to April 2024 was completed to determine the proportion of treatment articles that reported demographic information related to diversity. Studies were reviewed by trained raters using a standardized data extraction protocol with a consensus protocol. Results: While participant age and sex/gender were reported in nearly all studies (99% and 100%, respectively), only 24% of studies reported on race/ethnicity, 15% provided information on participants' language background, and none reported socioeconomic status. Among studies that included race/ethnicity, 89% of the participants were White, with minimal representation of other racial/ethnic groups. Conclusions: The underreporting of race/ethnicity, language background, and socioeconomic factors limits the generalizability and ecological validity of AOS treatment research. The field must prioritize inclusive participant recruitment and consistent demographic reporting. We propose a practical template for use in both research and clinical contexts to support more thorough data collection and to inform future work in diagnosis, assessment, and intervention for AOS. Supplemental Material: https://doi.org/10.23641/asha.31172353
Diabetes Management for Community Paramedics: Development and Implementation of a Novel Curriculum
Kasper, Anna L., Carlson, Peter N., Johnson, Rachel F., Schultz, Jeffery L., Meyer, Dustin, Liedl, Chad P., Juntunen, Michael B. , McCoy, Rozalina G. , Myers, Lucas A. , McCoy, Rozalina Grubina

Mayo Clinic

Diabetes Spectrum | March 9, 2022 | Volume: 35 | Issue: 3 | Pages: 367-376

10.2337/ds21-0095 | PMID 36082010 Get It

Previsit breast cancer educational microlearning videos: Impact on patient satisfaction and engagement.
Hurley, Rachel M. , Wyatt, Kirk D. , Johnson, Rachel F, O’Brien, Michael W., Zenz, Wendy J, Anderson, Stacy R, Brugger, C, Ruddy, Kathryn J. , Pruthi, Sandhya , Johnson, Rachel F., Brugger, Cheryl A, Boughey, Judy C.

Mayo Clinic

Journal of Clinical Oncology | May 27, 2019 | Volume: 37 | Issue: 15_suppl | Pages: 6526-6526

10.1200/jco.2019.37.15_suppl.6526 Get It

6526 Background: Most patients diagnosed with breast cancer turn to the Internet to learn about their diagnosis; however, information online is often generic, challenging to navigate, and not expert-curated. To facilitate patient education and engagement in our breast clinic, we piloted the implementation of pre-visit education via brief microlearning videos organized within an online platform. Methods: Seventeen videos of 2-4 minute duration were developed by multidisciplinary content experts. Videos covered a variety of educational topics relevant to breast cancer, including treatment options. Patients received a link via email to create an account, which provided access to the platform. Aggregate viewing data and optional patient surveys (online after viewing 3 videos and at the clinical appointment) were used to assess opt-in rates, engagement, and satisfaction. Results: Between September 2018 and January 2019, 57.4% (240/418) of women with biopsy proven breast cancer who were sent an email invitation registered on the platform. On average, patients watched 11 of the 17 videos, with 93.7% of users (225/240) viewing at least one. Overall, 85% (168/198) of women recommend the microlearning format for patient education. The most-viewed video topics included types of breast cancer, breast abnormality and biopsy, understanding biopsy results, tumor markers, and staging. Seventy-eight percent (154/198) of women reported that they planned to share the videos with family or caregivers, and 67% (133/198) felt that the educational content increased their satisfaction with their overall experience. Barriers to video access were emails marked as junk, not having an email address, and difficulties with videos loading. Conclusions: The majority of patients participating in this pilot registered on the platform and watched pre-visit microlearning educational videos. These expert-curated videos contributed to high levels of satisfaction and engagement. Strategies to overcome barriers to access will be developed to expand the reach of this new valuable component of breast cancer care.
CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells
Rollins, Meagan R. , Johnson, Rachel M. Gibbons , Gibbons Johnson, Rachel M

Mayo Clinic

Journal of Immunology Research | October 18, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-6

10.1155/2017/7659462 | PMID 29181416 Get It

Tumor cells are capable of limiting antitumor CD8+ T cell responses through their cell surface expression of PD-L1. In addition to PD-1 expressed by CD8+ T cells, PD-L1 also binds to CD80 expressed by CD8+ T cells. The influence of the PD-L1/CD80 interaction on CD8+ T cell function has not been fully characterized, so we sought to investigate the impact of the PD-L1/CD80 interaction on PD-L1-induced apoptosis of activated CD8+ T cells. We found that CD8+ T cells that lacked CD80 expression got activated to the same extent as wild-type CD8+ T cells, but when cultured with anti-CD3 and PD-L1/Fc protein, activated CD8+ T cells that lacked CD80 expression survived better than activated wild-type CD8+ T cells. These findings indicate that PD-L1 induces apoptosis in activated CD8+ T cells in part by signaling through CD80. Thus, in the design and implementation of checkpoint blockade therapies that target PD-L1, it is essential that both binding partners for PD-L1, PD-1, and CD80 are considered.
Motor learning guided treatment for acquired apraxia of speech: a case study investigating factors that influence treatment outcomes
Johnson, Rachel K. , Lasker, Joanne P. , Stierwalt, Julie A. G., MacPherson, Megan K. , LaPointe, Leonard L., Johnson, Rachel

Mayo Clinic

Speech, Language and Hearing | October 11, 2017 | Volume: 21 | Issue: 4 | Pages: 213-223

10.1080/2050571x.2017.1388488 Get It